Investing Profile

Anders Hove

VCFounderInvestor
Partner and Founder at Acorn Bioventures
acornbioventures.comNew York, New York
Photo of Anders Hove, Partner at Acorn Bioventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
INSEAD Network
80 CONNECTIONS
Venrock Network
21 CONNECTIONS
cb
$100K - $5.0M
$1.5M
21
CompanyStageDateRound SizeTotal Raised
Intuity Medical
Series UnknownNov 2016$40M
Series UnknownJan 2014$6M
Series UnknownAug 2012$12M
Series DAug 2011$12M
Series DJan 2010$64M
$220M
Co-investors: Casey Tansey (U.S. Venture Partners (USVP)), Eric Aguiar (Aisling Capital), Scott Bluestein (Hercules Capital)
Edge Therapeutics
Series CApr 2015$56M
$56M
Co-investors: James Healy (Sofinnova Investments)
Mevion Medical Systems
Private EquityAug 2014$200M
Private EquityJun 2013$55M
Series UnknownJan 2012$45M
Series UnknownJan 2009$33M
Series COct 2007$7M
$340M
Coherus Biosciences
Series CMay 2014$55M
$55M
Virdante Pharmaceuticals
Series ANov 2009$30M
$30M
Anacor Pharmaceutical
Series EJan 2009$50M
Series CMay 2005$25M
$87M
Co-investors: Paul Klingenstein (Aberdare Ventures), Ling Wong (Highbury Group)
PEAK Surgical
Series CFeb 2008$21M
Series BSep 2006$8M
$29M
Adnexus
Series CAug 2007$16M
Series BJun 2006$27M
$56M
Co-investors: Alan Crane (Polaris Partners), Noubar Afeyan (Flagship Ventures)
Managing General Partner Venrock2004 - 2016
Portfolio manager of BB Biotech & CEO of Bellevue Asset Management Bellevue Asset Management1996 - 2003
Project Manager Novartis1992 - 1996
INSEAD Master of Business Administration (MBA) Finance, General
Københavns Universitet Doctor of Medicine (M.D.) Biology, General
Danmarks Tekniske Universitet Master of Science (MSc) Biotechnology